Mediators of sympathetic activation in metabolic syndrome obesity.
about
Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic SyndromeNeuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic SyndromeControl of metabolic and cardiovascular function by the leptin-brain melanocortin pathwayObesity and adipokines: effects on sympathetic overactivityMetabolic syndrome and the hepatorenal reflexAssociation of glucose homeostasis measures with heart rate variability among Hispanic/Latino adults without diabetes: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)Muscle Sympathetic Nerve Activity Is Associated with Liver Insulin Sensitivity in Obese Non-Diabetic Men.Heart of the matter: coronary dysfunction in metabolic syndrome.Diabetes impairs hematopoietic stem cell mobilization by altering niche function.Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjectsThe role of the sympathetic nervous system in obesity-related hypertensionThe brain melanocortin system, sympathetic control, and obesity hypertension.Benefit of physical fitness against inflammation in obesity: role of beta adrenergic receptors.Relationship of muscle sympathetic nerve activity to insulin sensitivitySleep symptoms predict the development of the metabolic syndrome.Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats.Early life stress interacts with the diet deficiency of omega-3 fatty acids during the life course increasing the metabolic vulnerability in adult rats.Physical exercise performance in temperate and warm environments is decreased by an impaired arterial baroreflex.Relationships of adrenoceptor polymorphisms with obesitySocial stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptationButyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.Diminished neurogenic femoral artery vasoconstrictor response in a Zucker obese rat model: differential regulation of NOS and COX derivatives.Increased cerebral oxygen metabolism and ischemic stress in subjects with metabolic syndrome-associated risk factors: preliminary observations.Cardiac Autonomic Nervous System Activation and Metabolic Profile in Young Children: The ABCD Study.Device-based approaches for renal nerve ablation for hypertension and beyond.Impaired systolic blood pressure recovery and heart rate recovery after graded exercise in patients with metabolic syndrome.Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammationBK channel β1-subunit deficiency exacerbates vascular fibrosis and remodelling but does not promote hypertension in high-fat fed obesity in mice.Autonomic nervous system in the control of energy balance and body weight: personal contributionsBasic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.Effects of insulin resistance and testosterone on the participation of cyclooxygenase isoforms in vascular reactivity.Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome.Role of leptin and central nervous system melanocortins in obesity hypertensionMetabolic syndrome and the hepatorenal reflex.Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome.Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.Effects of renal denervation on insulin resistance.Obesity-related hypertension and its remission following gastric bypass surgery - a review of the mechanisms and predictive factors.Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease.Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?
P2860
Q21284498-25075DF6-79F0-4902-83AF-07C3B5F59013Q26752744-5E3300BF-D9C7-4A9B-B8A4-39AFA4AF0AFCQ26824250-8D9C5126-2CA1-493C-855D-0AF433B3CF9CQ27000398-050F088D-9973-4D74-A06E-F50C34111772Q28073645-1591000C-C03A-4EF6-80D4-5A71F8342643Q28389812-1BBAFC99-5069-46DE-A832-44F7B807DD55Q30361143-3040188F-07EC-4641-9C84-19F963EA2BACQ30404992-8CE1B9EA-DDAF-4EE2-82FB-BFD7537B339FQ30543776-9EB5A43B-F269-4733-A5A1-8153CDCEC643Q33556676-205FB0DE-4C85-4D92-8479-1C21B3ABE1A0Q33622500-730264F0-8572-4386-8CED-404DC0092907Q33716111-4A36F2DF-6B94-4114-ABE5-FA7C2EEC7AB1Q33763828-97BF821E-E0EC-4030-A612-393B0D2752D7Q33988286-55555316-2C9C-419C-9EAB-C5DC8411B2ECQ34315428-918BF68F-909A-482A-A03F-2904A21FEB02Q34449768-1EA04675-7A76-44C1-92F1-BA0DEC79C335Q34685518-5D77FF79-20B1-4D77-B7C5-063D57A82385Q34951054-0877C032-7292-4A09-A086-57FE0044B2FEQ34974804-FC4A7257-2679-4F28-8F22-7EAF52E830A8Q34981749-F5BDAC1B-DAD9-4F1C-A869-730908751691Q35216136-14CB3468-0684-4E3B-8D9F-72DC8E83D79AQ35250236-EA56B286-D7EE-48BA-BCFC-25653F41AF4FQ35445958-8C404897-23F9-4D61-AA9F-3AEDC6C6EF04Q35783748-24AB1B54-16B6-45EF-A16D-46A861654C9AQ35830968-2C1F8038-4B51-4F7D-94BF-8377122AB736Q36151487-005A748C-2EE0-45C6-A214-4CBEC329FDD5Q36292908-91300E7D-2848-410C-B387-B5B5479227D4Q36550814-DE545555-D75D-48A8-B53D-E5D3A26D6D92Q36830886-08830720-4F29-4A53-90B9-8D928473D196Q36861695-D0FF2D40-C762-4E15-9CCC-1654494131B9Q36890451-924CA176-187A-4DD5-9C3E-E4B0462CDCB0Q37163519-616F88EB-C461-41A1-821B-ED2FD8726EDCQ37527168-46F4E6CF-BEE8-4254-AA08-18F1D71234F0Q37604638-B168AC2A-9A91-4DD9-A90A-86C8DCDC4E9AQ37832696-C04875F4-991D-4130-BAF1-549D696B6C6AQ37896170-3D7F9F4F-BF91-4FAD-BBB9-BB22C9C02FFCQ38067774-728B828E-CEF3-47AF-9E90-F805BEE5AAB5Q38067796-9F0770E6-9A28-4BD7-89AC-411C304CAC8DQ38164265-913528CC-BAD9-4FAC-8D89-B74D1C4AC031Q38484107-B556CF32-21DC-4A49-A1DB-78E1BCCC4CFF
P2860
Mediators of sympathetic activation in metabolic syndrome obesity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mediators of sympathetic activation in metabolic syndrome obesity.
@en
Mediators of sympathetic activation in metabolic syndrome obesity.
@nl
type
label
Mediators of sympathetic activation in metabolic syndrome obesity.
@en
Mediators of sympathetic activation in metabolic syndrome obesity.
@nl
prefLabel
Mediators of sympathetic activation in metabolic syndrome obesity.
@en
Mediators of sympathetic activation in metabolic syndrome obesity.
@nl
P2093
P2860
P1476
Mediators of sympathetic activation in metabolic syndrome obesity.
@en
P2093
Murray D Esler
Nina Eikelis
Nora E Straznicky
P2860
P2888
P304
P356
10.1007/S11906-008-0083-1
P577
2008-12-01T00:00:00Z